← Back to Search

Electronic Cigarette

E-cigarette (EC) for Chronic Obstructive Pulmonary Disease

N/A

Waitlist Available

Led By Scott E. Sherman, MD, MPH

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

Study Summary

This trial will study whether e-cigarettes are more effective than nicotine replacement therapy in helping people with COPD quit smoking.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Average change in score on the mMRC Dyspnea Scale

Number of participants who achieve 50% reduction in Cigarettes Per Day (CPD)

Secondary outcome measures

Chronic Obstructive Airway Disease

Change in score of Clinical COPD Questionnaire (CCQ)

Number of participants who reported additional use of tobacco products and/or marijuana

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: E-cigarettes (EC)Experimental Treatment2 Interventions

EC + Counseling

Group II: Nicotine Replacement Therapy (NRT)Active Control2 Interventions

NRT + Counseling

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Smoking Harm Reduction Counseling Sessions

2020

N/A

~150

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor

1,368 Previous Clinical Trials

839,580 Total Patients Enrolled

Scott E. Sherman, MD, MPHPrincipal InvestigatorNYU Langone Health

Elizabeth Stevens, PhD, MPHPrincipal InvestigatorNYU Langone Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to enroll in this experiment?

"This clinical experiment has an aegis of 21-75 and requires that participants experience chronic obstructive airway disease. A total of 120 people are being accepted into the study."

Answered by AI

Does this trial accept elderly participants aged 70 or above?

"Patients who wish to take part in this clinical trial must be between 21 and 75 years old. Conversely, there are 11 studies available for those under 18 whilst 266 exist for elderly individuals over 65."

Answered by AI

Is this survey enrolling participants at present?

"Clinicaltrials.gov confirms that this trial, which was initiated November 9th 2020 and last updated August 25th 2022, is not actively recruiting patients at this moment in time. However, the same site provides a list of 271 other medical trials currently open for enrolment."

Answered by AI